These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


248 related items for PubMed ID: 23716047

  • 1. Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7.
    Pulido D, Torrent M, Andreu D, Nogués MV, Boix E.
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3797-805. PubMed ID: 23716047
    [Abstract] [Full Text] [Related]

  • 2. Exploring the mechanisms of action of human secretory RNase 3 and RNase 7 against Candida albicans.
    Salazar VA, Arranz-Trullén J, Navarro S, Blanco JA, Sánchez D, Moussaoui M, Boix E.
    Microbiologyopen; 2016 Oct; 5(5):830-845. PubMed ID: 27277554
    [Abstract] [Full Text] [Related]

  • 3. Human Antimicrobial RNases Inhibit Intracellular Bacterial Growth and Induce Autophagy in Mycobacteria-Infected Macrophages.
    Lu L, Arranz-Trullén J, Prats-Ejarque G, Pulido D, Bhakta S, Boix E.
    Front Immunol; 2019 Oct; 10():1500. PubMed ID: 31312205
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.
    Sánchez D, Moussaoui M, Carreras E, Torrent M, Nogués V, Boix E.
    Biochimie; 2011 Feb; 93(2):331-8. PubMed ID: 20951760
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides.
    Salazar VA, Arranz-Trullén J, Prats-Ejarque G, Torrent M, Andreu D, Pulido D, Boix E.
    Int J Mol Sci; 2019 Sep 14; 20(18):. PubMed ID: 31540052
    [Abstract] [Full Text] [Related]

  • 8. A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities.
    Pulido D, Prats-Ejarque G, Villalba C, Albacar M, González-López JJ, Torrent M, Moussaoui M, Boix E.
    Antimicrob Agents Chemother; 2016 Oct 14; 60(10):6313-25. PubMed ID: 27527084
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. RNase A ribonucleases and host defense: an evolving story.
    Rosenberg HF.
    J Leukoc Biol; 2008 May 14; 83(5):1079-87. PubMed ID: 18211964
    [Abstract] [Full Text] [Related]

  • 11. Structural determinants of the eosinophil cationic protein antimicrobial activity.
    Boix E, Salazar VA, Torrent M, Pulido D, Nogués MV, Moussaoui M.
    Biol Chem; 2012 Aug 14; 393(8):801-15. PubMed ID: 22944682
    [Abstract] [Full Text] [Related]

  • 12. The antipathogen activities of eosinophil cationic protein.
    Boix E, Torrent M, Sánchez D, Nogués MV.
    Curr Pharm Biotechnol; 2008 Jun 14; 9(3):141-52. PubMed ID: 18673279
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Towards the rational design of antimicrobial proteins: single point mutations can switch on bactericidal and agglutinating activities on the RNase A superfamily lineage.
    Pulido D, Moussaoui M, Nogués MV, Torrent M, Boix E.
    FEBS J; 2013 Nov 14; 280(22):5841-52. PubMed ID: 23992292
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure.
    Pulido D, Moussaoui M, Andreu D, Nogués MV, Torrent M, Boix E.
    Antimicrob Agents Chemother; 2012 May 14; 56(5):2378-85. PubMed ID: 22330910
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ribonucleases in HIV type 1 inhibition: effect of recombinant RNases on infection of primary T cells and immune activation-induced RNase gene and protein expression.
    Bedoya VI, Boasso A, Hardy AW, Rybak S, Shearer GM, Rugeles MT.
    AIDS Res Hum Retroviruses; 2006 Sep 14; 22(9):897-907. PubMed ID: 16989616
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
    Torrent M, Nogués MV, Boix E.
    J Mol Recognit; 2011 Sep 14; 24(1):90-100. PubMed ID: 20213669
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.